Athena_GTX

Home>Tag:Athena_GTX
Oct 1 2024

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

By |2024-11-28T06:29:43-05:00October 1st, 2024|Featured, Investor News, Press Releases|0 Comments

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 ...

Read More
Sep 11 2024

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

By |2024-09-10T19:05:30-04:00September 11th, 2024|Featured, Investor News, News, Press Releases|0 Comments

Breaking News: Development Just In! Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI Jackson Center, PA September 11, 2024 – Halberd Corporation (OTC-PINK: "HALB”), in coordination with Athena Telemedicine Partners (ATP), and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with ...

Read More
INVESTOR/MEDIA INQUIRIES

MEDICAL METAVERSE

As part of our efforts to remain at the forefront of breakthrough technologies in the medical and scientific fields, Halberd Corporation is engaged in scientific study and research in the fields of medicine, the prevention, treatment and management of illness and infections and rapid tests to identify infection, and other medical maladies.

To learn more about how we can further your efforts, or to partner with Halberd on specific healthcare solutions, please email: info@halberdcorporation.com

Go to Top